Filing Details
- Accession Number:
- 0001140361-13-011334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-07 17:31:53
- Reporting Period:
- 2013-03-05
- Filing Date:
- 2013-03-07
- Accepted Time:
- 2013-03-07 17:31:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184151 | R Conan Deady | One Idexx Drive Westbrook ME 04092 | Corp Vp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-05 | 2 | $34.37 | 2,227 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-03-05 | 3,609 | $53.31 | 5,836 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-03-05 | 2,419 | $87.42 | 8,255 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-05 | 6,030 | $91.72 | 2,225 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2013-03-05 | 2 | $0.00 | 2 | $34.37 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-03-05 | 3,609 | $0.00 | 3,609 | $53.31 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-03-05 | 2,419 | $0.00 | 2,419 | $87.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,909 | 2016-02-13 | No | 4 | M | Direct | |
| 5,341 | 2017-02-13 | No | 4 | M | Direct | |
| 8,532 | 2019-02-13 | No | 4 | M | Direct |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $91.70 to $91.78, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010 and 02/14/2013, and the remaining 2,909 shares on 02/14/2014.
- Grant of options to buy shares of common stock becomes exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014, and the remaining 1,733 shares on 02/14/2015.
- Grant of options to buy shares of common stock becomes exercisable as to 2,419 shares on 02/14/2013, 02/14/2014, 02/14/2015 and 02/14/2016, and the remaining 1,275 shares on 02/14/2017.
Billionaire Hedge Funds
